Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted equity ...
Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that members of the management team are scheduled to p ...
Insider Monkey on MSN10d
Is Geron Corp. (GERN) the Best Nasdaq Stock Under $5 to Buy?We recently published a list of 10 Best Nasdaq Stocks Under $5 to Buy. In this article, we are going to take a look at where ...
B. Riley dropped their FY2025 earnings per share (EPS) estimates for shares of Geron in a research report issued to clients ...
B. Riley decreased their FY2027 earnings estimates for shares of Geron in a research note issued to investors on Tuesday, ...
FOSTER CITY, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted equity awards covering an aggregate of ...
Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted equity awards covering an aggregate of 180,000 shares of its common stock ...
In this article, we are going to take a look at where Geron Corp. (NASDAQ:GERN) stands against other best Nasdaq stocks under $5 to buy. The Nasdaq is one of the top three most-followed stock ...
Stay informed and make data-driven decisions with the assistance of our Ratings Table. Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback